Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.448
+0.014 (3.13%)
At close: Jun 26, 2026, 4:00 PM EDT
0.456
+0.008 (1.85%)
After-hours: Jun 26, 2026, 7:26 PM EDT
Vivos Therapeutics Stock Forecast
VVOS's stock price has decreased by -85.32% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Vivos Therapeutics stock have an average target of 2.45, with a low estimate of 1.75 and a high estimate of 3.10. The average target predicts an increase of 447.36% from the current stock price of 0.45.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Vivos Therapeutics stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant | Ascendiant | Buy Reiterates $3 → $3.1 | Buy | Reiterates | $3 → $3.1 | +592.58% | Jun 4, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +458.53% | Apr 17, 2026 |
| Alliance Global Partners | Alliance Global Partners | Hold Maintains $2.5 → $1.75 | Hold | Maintains | $2.5 → $1.75 | +290.97% | Apr 17, 2026 |
Financial Forecast
Revenue This Year
23.12M
from 17.44M
Increased by 32.55%
Revenue Next Year
34.51M
from 23.12M
Increased by 49.26%
EPS This Year
-1.82
from -2.07
EPS Next Year
-0.84
from -1.82
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 24.1M | 45.1M |
| Avg | 23.1M | 34.5M |
| Low | 22.1M | 24.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 38.4% | 95.0% |
| Avg | 32.5% | 49.3% |
| Low | 26.7% | 6.0% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -1.50 | - |
| Avg | -1.82 | -0.84 |
| Low | -2.14 | -2.17 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.